Table II.
Comparison of clinical data of age- and sex-matched US and German patients with fibromyalgia syndrome.
USA n=71 | Germany n=71 | p-value | |
---|---|---|---|
Mean years since chronic widespread pain (SD) | 16.0 (12.4) | 7.6 (6.4) | Z = −5.5, p<0.0001 |
Mean years since fibromyalgia diagnosis (SD) | 11.6 (8.0) | 7.6 (6.4) | Z = −5.5; p<0.0001 |
Mean number of pain sites polysymptomatic distress scale (SD) (0–19) | 11.2 (4.2) | 12.9 (4.0) | Z = −2.3; p=0.02 |
Mean somatic symptom score polysymptomatic distress scale (SD) (0–12) | 8.8 (2.1) | 8.7 (2.2) | Z = −0.2; p=0.87 |
Mean total score polysymptomatic distress scale (SD) (0–31) | 19.9 (5.1) | 21.6 (5.1) | Z = −1.7; p=0.02 |
Psychological distress Patient Health Questionnaire 4 total score (SD) (0–12) | 4.6 (3.4) | 6.0 (3.5) | Z = −2.4; p=0.02 |
Patient Health Questionnaire potential depressive disorder n (%) | 29 (43.9) | 37 (56.1) | χ2 = 5.6; p=0.06 |
Patient Health Questionnaire potential anxiety disorder n (%) | 27 (42.2) | 37 (57.6) | χ2 = 2.8; p=0.06 |
Probable posttraumatic stress disorder n (%) | 24 (33.8) | 24 (33.8) | |
Mean Pain Disability Index total score (SD) (0–70) | 37. (16.2) | 36.0 (12.4) | Z = −0.8; p=0.45 |
Significant (Bonferroni adjusted) differences are marked as bold.